PMGC Holdings Inc.
ELAB Nasdaq Pharmaceutical Preparations Financials FY2022–FY2025
Revenue
Total sales reported in the income statement.
$0.6M
vs prior year
Operating margin
Operating income as a share of revenue.
—
Net income
Profit after all expenses, interest and tax.
−$7.7M
Free cash flow
Cash from operations minus capital spending.
−$6.4M
Return on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
—
Market cap
Last close times the latest diluted share count, so it is approximate.
—
P/E
Last close divided by diluted earnings per share over the last four quarters.
—
What PMGC Holdings Inc. does
No business description yet.
- Legal name
- PMGC Holdings Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 30, 2026
- Accession · CIK
- 0001213900-26-035937
0001840563
Revenue and margins
PMGC Holdings Inc. had $0.6M of revenue in fiscal 2025.
FY22
Revenue $0.8M
FY23
Revenue $1.7M
FY24
Revenue —
FY25
Revenue $0.6M
Q3 '23
Revenue $0.6M
Q4 '23
Revenue $0.7M
Q1 '24
Revenue $0.6M
Q2 '24
Revenue $0.6M
Q3 '24
Revenue $0.5M
Q4 '24
Revenue —
Q1 '25
Revenue —
Q2 '25
Revenue —
Q3 '25
Revenue $0.3M
Q4 '25
Revenue $0.3M
Q1 '26
Revenue $0.7M
Q2 '26
Revenue $1.3M
FY22
Gross 58.4%
Operating —
Net −234.9%
FCF —
FY23
Gross 66.3%
Operating —
Net −251.2%
FCF −266.7%
FY24
Gross —
Operating —
Net —
FCF —
FY25
Gross 31.4%
Operating —
Net −1,313.0%
FCF −1,080.5%
Gross
Operating
Net
FCF
Q3 '23
Gross 66.0%
Operating −141.6%
Net −141.2%
FCF −92.7%
Q4 '23
Gross 66.1%
Operating —
Net −165.7%
FCF −341.9%
Q1 '24
Gross 72.5%
Operating −273.9%
Net −227.4%
FCF −379.6%
Q2 '24
Gross 72.6%
Operating −232.6%
Net −233.3%
FCF −128.9%
Q3 '24
Gross 74.7%
Operating −118.6%
Net −284.6%
FCF −72.4%
Q4 '24
Gross —
Operating —
Net —
FCF —
Q1 '25
Gross —
Operating —
Net —
FCF —
Q2 '25
Gross —
Operating —
Net —
FCF —
Q3 '25
Gross 27.3%
Operating −769.1%
Net −907.4%
FCF —
Q4 '25
Gross 35.3%
Operating —
Net −980.8%
FCF −689.5%
Q1 '26
Gross 33.8%
Operating —
Net −728.3%
FCF −490.1%
Q2 '26
Gross 29.5%
Operating —
Net −225.1%
FCF −150.0%
Gross
Operating
Net
FCF
Net income and earnings per share
Loss periods are shown in red.
FY22
Net income −$1.8M
FY23
Net income −$4.3M
FY24
Net income −$6.2M
FY25
Net income −$7.7M
Q3 '23
Net income −$0.8M
Q4 '23
Net income −$1.2M
Q1 '24
Net income −$1.4M
Q2 '24
Net income −$1.4M
Q3 '24
Net income −$1.5M
Q4 '24
Net income −$1.9M
Q1 '25
Net income −$1.6M
Q2 '25
Net income −$0.6M
Q3 '25
Net income −$2.6M
Q4 '25
Net income −$3.0M
Q1 '26
Net income −$5.0M
Q2 '26
Net income −$2.9M
FY22
Diluted EPS −$0.19
FY23
Diluted EPS −$0.40
FY24
Diluted EPS —
FY25
Diluted EPS —
Q3 '23
Diluted EPS −$0.08
Q4 '23
Diluted EPS −$0.08
Q1 '24
Diluted EPS −$0.08
Q2 '24
Diluted EPS −$0.08
Q3 '24
Diluted EPS −$0.07
Q4 '24
Diluted EPS —
Q1 '25
Diluted EPS —
Q2 '25
Diluted EPS —
Q3 '25
Diluted EPS —
Q4 '25
Diluted EPS —
Q1 '26
Diluted EPS —
Q2 '26
Diluted EPS —
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
FY22
Return on capital —
Return on equity −159.1%
Return on assets −95.1%
FY23
Return on capital —
Return on equity −173.5%
Return on assets −121.5%
FY24
Return on capital —
Return on equity −119.1%
Return on assets −88.1%
FY25
Return on capital —
Return on equity −106.9%
Return on assets −70.9%
Return on capital
Return on equity
Return on assets
Cash flow
Free cash flow was −$6.4M in fiscal 2025, −1,080.5% of revenue. Cash from operations minus capital spending.
FY22
Free cash flow —
FY23
Free cash flow −$4.6M
FY24
Free cash flow −$5.5M
FY25
Free cash flow −$6.4M
Q3 '23
Free cash flow −$0.5M
Q4 '23
Free cash flow −$2.4M
Q1 '24
Free cash flow −$2.3M
Q2 '24
Free cash flow −$0.8M
Q3 '24
Free cash flow −$0.4M
Q4 '24
Free cash flow −$2.0M
Q1 '25
Free cash flow —
Q2 '25
Free cash flow —
Q3 '25
Free cash flow —
Q4 '25
Free cash flow −$2.1M
Q1 '26
Free cash flow −$3.3M
Q2 '26
Free cash flow −$2.0M
FY22
Cash from operations −$1.6M
Capital spending —
FY23
Cash from operations −$4.6M
Capital spending $0.0M
FY24
Cash from operations −$5.5M
Capital spending $0.0M
FY25
Cash from operations −$5.9M
Capital spending $0.4M
Cash from operations
Capital spending
Q3 '23
Cash from operations −$0.5M
Capital spending $0.0M
Q4 '23
Cash from operations −$2.4M
Capital spending $0.0M
Q1 '24
Cash from operations −$2.3M
Capital spending $0.0M
Q2 '24
Cash from operations −$0.8M
Capital spending $0.0M
Q3 '24
Cash from operations −$0.4M
Capital spending $0.0M
Q4 '24
Cash from operations −$2.0M
Capital spending $0.0M
Q1 '25
Cash from operations −$1.3M
Capital spending —
Q2 '25
Cash from operations −$1.3M
Capital spending —
Q3 '25
Cash from operations −$1.5M
Capital spending —
Q4 '25
Cash from operations −$1.8M
Capital spending $0.3M
Q1 '26
Cash from operations −$3.0M
Capital spending $0.4M
Q2 '26
Cash from operations −$2.0M
Capital spending −$0.0M
Cash from operations
Capital spending
Dividends, buybacks and share count
PMGC Holdings Inc. returned — to shareholders in fiscal 2025. The diluted share count rose 0.0%.
FY22
Dividends —
Buybacks —
FY23
Dividends —
Buybacks —
FY24
Dividends —
Buybacks —
FY25
Dividends —
Buybacks —
Dividends
Buybacks
FY22
Diluted shares —
FY23
Diluted shares —
FY24
Diluted shares —
FY25
Diluted shares —
Balance sheet
Cash, debt and the ratios that show how comfortably PMGC Holdings Inc. can carry it.
FY22
Cash $1.2M
Debt —
FY23
Cash $3.3M
Debt —
FY24
Cash $4.0M
Debt —
FY25
Cash $6.0M
Debt —
Cash
Debt
| Fiscal year end | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Cash and short-term investments | $1.2M | $3.3M | $4.0M | $6.0M |
| Current ratio | 2.6x | 3.8x | 3.4x | 1.7x |
| Quick ratio | 2.2x | 3.4x | 3.4x | 1.7x |
| Total assets | $1.9M | $5.2M | $9.0M | $12.9M |
| Total liabilities | $0.8M | $1.4M | $2.3M | $5.0M |
| Shareholders' equity | $1.1M | $3.8M | $6.7M | $7.8M |
| Net debt (− = net cash) | — | — | — | — |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Net income is positive | ✕ | ✕ | ✕ | ✕ |
| Cash from operations is positive | ✕ | ✕ | ✕ | ✕ |
| Return on assets rose | — | ✓ | ✓ | ✓ |
| Cash from operations exceeds net income | ✓ | ✕ | ✓ | ✓ |
| Debt fell relative to assets | — | — | — | — |
| Current ratio rose | — | ✓ | ✕ | ✕ |
| Share count didn't rise | — | — | — | — |
| Gross margin rose | — | ✓ | — | — |
| Revenue rose relative to assets | — | ✕ | — | — |
| F-score | — / 3 | 3 / 7 | — / 5 | — / 5 |
| Accruals ratio | −11.3% | 7.2% | −10.7% | −16.6% |
| Altman Z'' | — | — | — | — |
4 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $0.8M | $1.7M | — | $0.6M |
| Gross profit | $0.4M | $1.1M | — | $0.2M |
| Research and development | $0.2M | $0.0M | $0.1M | $0.1M |
| Interest expense | $0.0M | $0.0M | $0.7M | $0.3M |
| Pretax income | — | — | −$4.0M | −$7.7M |
| Income tax | — | — | — | $0.0M |
| Net income | −$1.8M | −$4.3M | −$6.2M | −$7.7M |
| Diluted EPS | −$0.19 | −$0.40 | — | — |
| Cash flow | ||||
| Cash from operations | −$1.6M | −$4.6M | −$5.5M | −$5.9M |
| Capital expenditure | — | $0.0M | $0.0M | $0.4M |
| Free cash flow | — | −$4.6M | −$5.5M | −$6.4M |
| Depreciation and amortization | $0.0M | $0.0M | $0.0M | $0.1M |
| Stock-based compensation | $0.2M | $0.5M | $0.1M | −$0.0M |
| Acquisitions | — | — | — | $2.2M |
| Balance sheet | ||||
| Cash and short-term investments | $1.2M | $3.3M | $4.0M | $6.0M |
| Current assets | $1.6M | $4.9M | $6.1M | $6.9M |
| Current liabilities | $0.6M | $1.3M | $1.8M | $3.9M |
| Inventory | $0.2M | $0.5M | — | $0.1M |
| Property and equipment, net | $0.1M | $0.0M | $0.0M | $0.9M |
| Goodwill | — | — | — | $1.0M |
| Intangible assets | — | — | $2.8M | $2.9M |
| Total assets | $1.9M | $5.2M | $9.0M | $12.9M |
| Total liabilities | $0.8M | $1.4M | $2.3M | $5.0M |
| Shareholders' equity | $1.1M | $3.8M | $6.7M | $7.8M |
| Margins | ||||
| Gross margin | 58.4% | 66.3% | — | 31.4% |
| Net margin | −234.9% | −251.2% | — | −1,313.0% |
| FCF margin | — | −266.7% | — | −1,080.5% |
| Returns | ||||
| Return on equity | −159.1% | −173.5% | −119.1% | −106.9% |
| Return on assets | −95.1% | −121.5% | −88.1% | −70.9% |
| Return on tangible equity | −159.1% | −112.4% | −161.9% | −195.3% |
| Growth | ||||
| Revenue growth | — | 123.5% | — | — |
| Financial health | ||||
| Current ratio | 2.6x | 3.8x | 3.4x | 1.7x |
| Quick ratio | 2.2x | 3.4x | 3.4x | 1.7x |
| Capital allocation | ||||
| Capex / revenue | — | 0.7% | — | 75.0% |
| Stock comp / revenue | 22.4% | 28.5% | — | −3.3% |
| Quality scores | ||||
| Piotroski F-score | — | 3.0 | — | — |
| Accruals ratio | −11.3% | 7.2% | −10.7% | −16.6% |
Source: SEC EDGAR XBRL filings (CIK 0001840563). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.